Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
This study has been withdrawn prior to enrollment.
( Business decision brand strategy; no patients enrolled )
Study NCT00601978
Information provided by Novartis
First Received on January 11, 2008.
Last Updated on April 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
